Placing perfume on the EU market requires a chain of accountable evidence under Regulation (EC) No 1223/2009. The fragrance formula, safety assessment, Product Information File, notification, manufacturing evidence and label must describe the same finished product. Completing one item—such as an IFRA conformity document—does not replace the legal route.
Appoint the Responsible Person before market access
Every cosmetic product made available in the EU must have an EU-established Responsible Person. Define the role, address and document access contractually. The Responsible Person coordinates compliance and corrective action; an overseas manufacturer or marketplace listing does not remove that requirement.
Build the safety and product information file
A qualified safety assessor prepares the Cosmetic Product Safety Report from the finished formula, exposure, toxicological data, packaging and intended use. The broader Product Information File also contains product description, manufacturing method and GMP statement, proof of claimed effects where justified, and relevant animal-testing data.
Freeze the label from final data
Article 19 information includes the Responsible Person name and address, nominal content, durability or period-after-opening information where applicable, precautions, batch reference, product function where unclear and ingredient list. Language requirements depend on the Member State. Ingredient and fragrance-allergen declarations must come from the final formula, not an early quotation.
Notify the marketed product through CPNP
The Responsible Person submits required information through the Cosmetic Products Notification Portal before placing the product on the market. Notification is not an approval certificate. Formula, label, pack or market changes should enter change control so the safety file and notification can be reviewed.
EU launch file
- Signed Responsible Person scope and operator details
- Final quantitative formula and raw-material documentation
- CPSR and indexed PIF
- GMP/manufacturing evidence and batch traceability
- Final artwork and CPNP record
- Complaint, serious undesirable effect and recall procedure